Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Myeloblast (acute myeloid leukemia)
[{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2099/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2099/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2098/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2098/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2097/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2097/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2096/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2096/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2095/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2095/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2094/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2094/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2093/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2093/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2092/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2092/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2091/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2091/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2090/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2090/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208f/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208f/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208e/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208e/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208d/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208d/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208c/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208c/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208b/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208b/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a208a/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a208a/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2089/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2089/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2088/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2088/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2087/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2087/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2086/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2086/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2085/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2085/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2084/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2084/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2083/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2083/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2082/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2082/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2081/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2081/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2080/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2080/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207f/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207f/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207e/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207e/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207d/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207d/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207c/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207c/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207b/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207b/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a207a/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a207a/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2079/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2079/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2078/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2078/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2077/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2077/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2076/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2076/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2075/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2075/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2074/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2074/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2073/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2073/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2072/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2072/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2071/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2071/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2070/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2070/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206f/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206f/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206e/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206e/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206d/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206d/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206c/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206c/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206b/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206b/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a206a/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a206a/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2069/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2069/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2068/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2068/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2067/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2067/6218fcbec443a0002909e764.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/621d4b1090f44400296a2066/6218fcbec443a0002909e764.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/621d4b1090f44400296a2066/6218fcbec443a0002909e764.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
myeloblast,myeloid blast,myeloid,granulocyte,progenitor,acute myeloblastic leukemia,leukemia,stem cell,unipotent,granules,nucleoli,nucleus,auer rod,auer,bone marrow,sinus,marrow,myeloblast
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
